Acquisition of a ProteinSimple capillary electrophoresis protein immunoanalyzer

购置 ProteinSimple 毛细管电泳蛋白质免疫分析仪

基本信息

  • 批准号:
    8949379
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-04-01 至 2015-09-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): Request for a ProteinSimple Instrument. We are requesting the purchase of a ProteinSimple capillary electrophoresis protein immunoanalysis system (aka SallySue) for the high throughput cost effective analysis of proteins. This instrument utilizes capillary electrophoretic technology o separate proteins by size like standard sodium dodecyl sulfate poly acrylamide electrophoresis methodology. Subsequent immunodetection functions much like standard chemiluminescent immunoblotting approaches. The main advantages of the SallySue instrument over manual approaches are dramatically reduced hands on time, increased throughput, reduced materials cost, reduced sample consumption, increased quantitative accuracy, increased reproducibility, and lower variability. Adoption of capillary electrophoresis technology for DNA sequencing was the technological breakthrough permitting completion of the human genome project. Application of capillary electrophoresis to protein characterization promises to revolutionize conventional immunoblotting methods. This instrument will be placed in the Molecular Genetics Core facility located in Building 1, Room 710 at VAPSHCS, Seattle; as such it will be available for use by all investigators as a fee for use service. The instrument itself will be operated by trained core staf. Major users of the instrument include Steven Kahn, David Cook, Chang-en Yu, Nicole Liachko, and Brian Kraemer; minor users will be William Banks and Rebecca Hull. Overall, the instrument has utility for any molecular investigation focused on protein and has the potential to replace manual western blotting and ELISA analysis. Overall purchase of this instrument will be expected to increase the competitiveness of VA PSHCS as a research institution and further strengthen the effectiveness and efficiency of its investigators molecular work with protein. The instrument will return its cost many times over in terms of saved time and labor by reducing costs for immunoblotting analysis by up to 60%. Thus research teams will have freed up resources to pursue their objectives more rapidly and in greater depth allowing more rapid progress in research into traumatic brain injury, diabetes, dementia and amyotrophic lateral sclerosis.
 描述(由申请人提供): 申请ProteinSimple仪器。我们要求购买蛋白质简单毛细管电泳蛋白质免疫分析系统(又名SallySue),用于高通量、高性价比的蛋白质分析。该仪器利用毛细管电泳法分离蛋白质,就像标准的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳法。随后的免疫检测功能很像标准的化学发光免疫印迹方法。与人工方法相比,SallySue仪器的主要优势是大大减少了实际操作时间,增加了产量,降低了材料成本,减少了样品消耗,提高了定量准确性,增加了重复性,并降低了变异性。采用毛细管电泳法进行DNA测序是完成人类基因组计划的技术突破。毛细管电泳法在蛋白质鉴定中的应用有望彻底改变传统的免疫印迹方法。该仪器将放置在位于西雅图VAPSHCS的1号楼710室的分子遗传学核心设施中;因此,所有研究人员都可以使用它作为使用服务费。仪器本身将由训练有素的核心STAF操作。该乐器的主要用户包括史蒂文·卡恩、大卫·库克、余昌恩、妮可·利亚奇科和布莱恩·克莱默;次要用户将是威廉·班克斯和丽贝卡·赫尔。总体而言,该仪器对任何以蛋白质为重点的分子研究都是有用的,并有可能取代人工的Western blotting和ELISA分析。对这台仪器的整体购买预计将增加VA PSHCS作为研究机构的竞争力,并进一步加强其研究人员在蛋白质分子工作中的效力和效率。通过将免疫印迹分析的成本降低高达60%,该仪器将在节省时间和劳动力方面实现成倍的回报。因此,研究团队将腾出资源,更快、更深入地追求他们的目标,从而使创伤性脑损伤、糖尿病、痴呆症和肌萎缩侧索硬化症的研究取得更快的进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian C. Kraemer其他文献

Erratum to: Ethosuximide ameliorates neurodegenerative disease phenotypes by modulating DAF-16/FOXO target gene expression
  • DOI:
    10.1186/s13024-015-0051-6
  • 发表时间:
    2015-10-23
  • 期刊:
  • 影响因子:
    17.500
  • 作者:
    Xi Chen;Hannah V. McCue;Shi Quan Wong;Sudhanva S. Kashyap;Brian C. Kraemer;Jeff W. Barclay;Robert D. Burgoyne;Alan Morgan
  • 通讯作者:
    Alan Morgan
TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy
TMEM106B C 端片段聚集并驱动神经退行性蛋白病
  • DOI:
    10.1101/2024.06.11.598478
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ruben Riordan;Aleen D. Saxton;P. McMillan;Rebecca L. Kow;Nicole F. Liachko;Brian C. Kraemer
  • 通讯作者:
    Brian C. Kraemer
Yeast three-hybrid system to detect and analyze RNA-protein interactions.
用于检测和分析 RNA-蛋白质相互作用的酵母三杂交系统。
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Beilin Zhang;Brian C. Kraemer;D. Sengupta;S. Fields;Marvin Wickens
  • 通讯作者:
    Marvin Wickens
α-Methyl-α-phenylsuccinimide ameliorates neurodegeneration in a <em>C. elegans</em> model of TDP-43 proteinopathy
  • DOI:
    10.1016/j.nbd.2018.06.013
  • 发表时间:
    2018-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    Shi Quan Wong;Matthew G. Pontifex;Marie M. Phelan;Chandra Pidathala;Brian C. Kraemer;Jeff W. Barclay;Neil G. Berry;Paul M. O'Neill;Robert D. Burgoyne;Alan Morgan
  • 通讯作者:
    Alan Morgan
Alternative 3′ UTR polyadenylation is disrupted in the rNLS8 mouse model of ALS/FTLD
  • DOI:
    10.1186/s13041-025-01174-1
  • 发表时间:
    2025-01-14
  • 期刊:
  • 影响因子:
    2.900
  • 作者:
    Randall J. Eck;Paul N. Valdmanis;Nicole F. Liachko;Brian C. Kraemer
  • 通讯作者:
    Brian C. Kraemer

Brian C. Kraemer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian C. Kraemer', 18)}}的其他基金

SPOP drives neurodegenerative tauopathy
SPOP 驱动神经退行性 tau 病
  • 批准号:
    10734807
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Targeting MSUT2 with small molecules to ameliorate pathological tau
用小分子靶向 MSUT2 改善病理性 tau
  • 批准号:
    10735826
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Formation of Tau RNA Complexes disrupts tau function and drives tau neuropathology
Tau RNA 复合物的形成会破坏 tau 功能并驱动 tau 神经病理学
  • 批准号:
    10777174
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Developing MSUT2 Nanobodies for Targeting Pathological Tau in Alzheimer's Disease
开发 MSUT2 纳米抗体来靶向阿尔茨海默病中的病理性 Tau 蛋白
  • 批准号:
    10518408
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Developing MSUT2 Nanobodies for Targeting Pathological Tau in Alzheimer's Disease
开发 MSUT2 纳米抗体来靶向阿尔茨海默病中的病理性 Tau 蛋白
  • 批准号:
    10363866
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
使用 MSUT2 siRNA 缀合物逆转 Tau 病理学
  • 批准号:
    10240452
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Reversal of Tau Pathology with MSUT2 siRNA Conjugates
使用 MSUT2 siRNA 缀合物逆转 Tau 病理学
  • 批准号:
    9909831
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Protection from pathological tau by activation of the ER unfolded protein response
通过激活 ER 未折叠蛋白反应来预防病理性 tau 蛋白
  • 批准号:
    10347310
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Protection from pathological tau by activation of the ER unfolded protein response
通过激活 ER 未折叠蛋白反应来预防病理性 tau 蛋白
  • 批准号:
    10551219
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Protection from pathological tau by activation of the ER unfolded protein response
通过激活 ER 未折叠蛋白反应来预防病理性 tau 蛋白
  • 批准号:
    9901055
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了